Clidanac (CAS 34148-01-1) Suppliers and Product Information

Clidanac is a potent anti-inflammatory agent used for the relief of pain and inflammation related to arthrosis deformans, periarthritis humeroscapularis, cervical syndrome, and lumbago. It can uncouple oxidative phosphorylation and is primarily used as a reagent for laboratory research. Clidanac is also known by its trade names Britai (Bristol-Banyu, Japan) and Ind*** (Takeda, Japan).

Clidanac can be synthesized through a multi-step process involving formylation of cyclohexylbenzene, condensation with diethyl malonate, and subsequent reactions leading to the formation of 5-cyclohexyl-1-indanecarboxylic acid. The final step involves chlorination using N-chlorosuccinimide in DMF to produce clidanac.

Frequently Asked Questions about Clidanac

Q: What is the main use of Clidanac?

A: Clidanac is primarily used as a potent anti-inflammatory agent for relieving pain and inflammation associated with various musculoskeletal conditions such as arthrosis deformans, periarthritis humeroscapularis, cervical syndrome, and lumbago.

Q: Is Clidanac available for commercial use?

A: While Clidanac is available from various suppliers, it is often labeled as a reagent for laboratory use only. Its availability for commercial or medical use may vary depending on regulatory approvals in different countries.

Q: What is the typical purity of Clidanac offered by suppliers?

A: Based on the supplier information provided, the purity of Clidanac typically ranges from 98% to 99.9%, with most suppliers offering purities of 98% or higher.

Q: Are there any alternative names for Clidanac?

A: Yes, Clidanac is also known by its chemical name 6-chloro-5-cyclohexyl-2,3-dihydro-1H-indene-1-carboxylic acid and trade names such as Britai and Ind***.